pozanicline codenamed drug developed abbott nootropic neuroprotective animal studies suggested useful treatment subsequent human trials shown effective binds high affinity subtypeselective nicotinic acetylcholine receptors partial agonism subtypes familiar nicotine particularly low tendency cause side effects compared drugs making exciting candidate clinical development pozanicline synthesized boclprolinol dehydration reaction followed deprotection nitrogen atom httpsenwikipediaorgwikipozanicline